• 1
    Cambell P, Weiss U. Allergy and asthma. Nature 1999; 402:B138.
  • 2
    Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54:8257.
  • 3
    Rothenberg ME, Hogan SP. Overview. In: RothenbergME, ed. Chemokines in allergic disease. New York: Marcel Dekker, Inc., 2000:115.
  • 4
    Garcia-Zepeda EA, Rothenberg ME, Weremowicz S, Sarafi MN, Morton CC, Luster AD. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics 1997; 41:4716.
  • 5
    Nomiyama H, Osborne LR, Imai T et al. Assignment of the human CC chemokine MPIF-2/eotaxin-2 (SCYA24) to chromosome 7q11.23. Genomics 1998; 49:33940.
  • 6
    Guo RF, Ward PA, Hu SM, McDuffie JE, Huber-Lang M, Shi MM. Molecular cloning and characterization of a novel human CC chemokine, SCYA26. Genomics 1999; 58:3137.
  • 7
    White JR, Imburgia C, Dul E et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 1997; 62:66775.
  • 8
    Patel VP, Kreider BL, Li Y et al. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 1997; 185:116372.
  • 9
    Komiya A, Nagase H, Yamada H et al. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cell Immunol 2003; 225:91100.
  • 10
    Yang M, Hogan SP, Mahalingam S et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003; 112:93543.
  • 11
    Berkman N, Ohnona S. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 2001; 24:6827.
  • 12
    Ravensberg AJ, Ricciardolo FL, Zan Schadewijk A et al. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 2005; 115:77985.
  • 13
    Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 2005; 175:534150.
  • 14
    Till S, Dickason R, Huston D et al. IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin Immunol 1997; 99:5639.
  • 15
    Michel O, Ginanni R, Le Bon B, Content J, Duchateau J, Sergysels R. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis 1992; 146:3527.
  • 16
    Michel O, Kips J, Duchateau J et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154:16416.
  • 17
    Eldridge MW, Peden DB. Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2000; 105:47581.
  • 18
    Gereda JE, Leung DY, Thatayatikom A et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 2000; 355:16803.
  • 19
    Holt PG, Sly PD. Prevention of adult asthma by early intervention during childhood: potential value of new generation immunomodulatory drugs. Thorax 2000; 55:7003.
  • 20
    Tulic MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000; 22:60412.
  • 21
    Morris SC, Madden KB, Adamovicz JJ et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994; 152:104756.
  • 22
    Zuany-Amorim C, Creminon C, Nevers MC, Nahori MA, Vargaftig BB, Pretolani M. Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J Immunol 1996; 157:37784.
  • 23
    Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report, Bethesda, MD National Institutes of Health National Heart, Lung, and Blood Institute; 2002. NIH publication no. 02–3659. J Allergy Clin Immunol 2002; 110:S141219.
  • 24
    American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:22544.
  • 25
    Nahm DH, Park JW, Hong CS. Effects of autologous sera on immediate and late skin reaction to the house dust mite in atopic individuals. Yonsei Med J 1995; 36:13745.
  • 26
    Gleich GJ, Jones RT. Measurement of IgE antibodies by the radioallergosorbent test. I. Technical considerations in the performance of the test. J Allergy Clin Immunol 1975; 55:33445.
  • 27
    Humbert M, Menz G, Ying S et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20:52833.
  • 28
    Williams J, Johnson S, Mascali JJ, Smith H, Rosenwasser LJ, Borish L. Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol 1992; 149:28239.
  • 29
    Ying S, Meng Q, Zeibecoglou K et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4, and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999; 163:63219.
  • 30
    Shin HD, Kim LH, Park BL et al. Association of eotaxin gene family with asthma and serum total IgE. Hum Mol Genet 2003; 312:127985.
  • 31
    Min JW, Lee JH, Park CS et al. Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration. J Hum Genet 2005; 50:11823.
  • 32
    Iwamoto I, Nakajima H, Endo H, Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993; 177:5736.
  • 33
    Kips JC, Brusselle GJ, Joos GF et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996; 153:5359.
  • 34
    De AK, Miller-Graziano CL, Calvano SE et al. Selective activation of peripheral blood T cell subsets by endotoxin infusion in healthy human subjects corresponds to differential chemokine activation. J Immunol 2005; 175:615562.
  • 35
    Schenker MB, Christiani D, Cormier Y. Respiratory health hazards in agriculture. Am J Respir Crit Care Med 1998; 158:S176.
  • 36
    Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999; 402:B127.
  • 37
    Rizzo MC, Naspitz CK, Fernandez-Cladas E, Lockey RF, Mimica I, Sole D. Endotoxin exposure and symptoms in asthmatic children. Pediatr Allergy Immunol 1997; 8:1216.
  • 38
    Nightingale JA, Rogers DF, Hart LA, Kharitonov SA, Chung KF, Barnes PJ. Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax 1998; 53:56371.
  • 39
    Cheng SS, Lukacs NW, Kunkel SL. Eotaxin/CCL11 is a negative regulator of neutrophil recruitment in a murine model of endotoxemia. Exp Mol Pathol 2002; 73:18.
  • 40
    Spencer SD, Di Marco F, Hooley J et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 1998; 187:5718.
  • 41
    Rodriguez D, Keller AC, Faquim-Mauro EL et al. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003; 171:10018.
  • 42
    Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8:6259.